Article information
Full text is only aviable in PDF
REFERÊNCIAS BIBLIOGRÁFICAS
[1.]
National Heart, Lung and Blood Institute and World Health Organization.
Global Strategy for Asthma Management and Prevention, NHLBI/WHO, (1995),
[2.]
International Study of Asthma and Allergies in Childhood (ISAAC).
Worldwide variations in the prevalence of asthma symptoms: the International Study of Asthma and Allergies in Childhood (ISAAC).
Eur. Respir. J, (1998),
[3.]
Ibidem
[4.]
European Community Respiratory Health Survey.
Variations in the prevalence of respiratory symptoms, self-reported asthma attacks and use of asthma medication in European Community Respiratory Health Survey.
Eur. Respir. J, (1996),
[5.]
National Heart, Lung and Blood Institute and World Health Organization.
Global Strategy for Asthma Management and Prevention, NHLBI/WHO, (1995),
[6.]
DESPACHO MINISTERIAL No 6536/99; D.R. No77, II Série, 1/4/99, 4821
Copyright © 2001. Sociedade Portuguesa de Pneumologia/SPP
Special content about COVID-19
- Assisted mobilisation in critical patients with COVID-19
- Two years of COVID-19: Trends in rehabilitation
- Comparison of different field tests to assess the physical capacity of post-COVID-19 patients
- New insights in circulating peptidome to differentiate mild to severe COVID-19 patients: Preliminary report
Open access
This work is licensed under a Creative Commons Attribution 4.0 International License.
Publish in
Pulmonology
Pulmonology
- Home
- All contents
- Publish your article
- About the journal
- Metrics
- Open access
Article options